Brief: scPharmaceuticals Q3 Revenue USD 10.026 Million Vs. IBES Estimate USD 10.8 Million

Scpharmaceuticals

13/11/2024 21:01

Nov 13 (Reuters) - scPharmaceuticals Q3 net income USD -35.105 million vs.
IBES estimate USD -15.4 million.
* Q3 basic EPS USD -0.75
* Q3 operating expenses USD 28.172 million
* Q3 income from operations USD -18.146 million vs. IBES estimate USD -14.6
million